An expert explains the importance of genetic testing in metastatic colorectal cancer, as recent FDA approval highlights its ...

When Beatrice Dionigi was in medical school 15 years ago, she was taught that colon cancer—long known as a "silent killer" ...

Research reveals promising advancements of Ce6-GFFY in colorectal cancer treatment. Colorectal cancer (CRC) is a highly ...

A new study finds that cannabidiol (CBD) may effectively combat colorectal cancer (CRC), showing antitumor effects across ...

A gene called high mobility group A1 (HMGA1) may be the key that opens the door to the development of colon cancer, according ...

The intestinal epithelium is a highly dynamic barrier that regulates digestion, absorption, immune responses, and communication between the gut microbiota and the nervous system.

Dr. Marwan G. Fakih explains that KRAS mutations, found in 45% of patients with colorectal cancer, include the rare KRAS G12C mutation, leading to Lumakras approval.

The immune system plays a key role in detecting and destroying cancer cells. Cancer immunotherapy works by programming immune cells to recognize and eliminate cancer cells.

Three trials presented at ASCO GI 2025 will change practice and improve the treatment of colorectal cancer, according to experts.

Colon cancer is one of the most prevalent cancers globally, especially among adults over 45. Crucial in prevention and early detection, maintaining a healthy diet and consuming gut-friendly drinks ...

Pfizer’s metastatic colorectal cancer (mCRC ... the combination in mCRC patients living with a BRAF V600E mutation who are treatment-naive. The top-line data also saw statistically significant ...